End-of-day quote
BURSA MALAYSIA
03:30:00 26/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.215
MYR
|
+2.38%
|
|
+2.38%
|
-8.51%
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2023
|
---|
Capitalization
1 |
27.72
|
42.21
|
8.19
|
579.4
|
80.94
|
Enterprise Value (EV)
1 |
46.79
|
61.88
|
40.13
|
629.8
|
223.8
|
P/E ratio
|
-2.12
x
|
-4.12
x
|
-0.44
x
|
-38.4
x
|
-1.14
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.12
x
|
1.28
x
|
0.37
x
|
26
x
|
16.7
x
|
EV / Revenue
|
6.95
x
|
1.88
x
|
1.83
x
|
28.3
x
|
46.1
x
|
EV / EBITDA
|
-5.26
x
|
-32.9
x
|
-10.7
x
|
-98.9
x
|
-4.19
x
|
EV / FCF
|
-
|
3,13,03,643
x
|
43,59,866
x
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
-
|
-
|
Price to Book
|
0.62
x
|
1.22
x
|
0.39
x
|
6.24
x
|
2.3
x
|
Nbr of stocks (in thousands)
|
1,26,000
|
1,26,000
|
1,26,000
|
2,84,000
|
2,84,000
|
Reference price
2 |
0.2200
|
0.3350
|
0.0650
|
2.040
|
0.2850
|
Announcement Date
|
31/10/18
|
31/10/19
|
30/10/20
|
28/01/22
|
28/07/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2023
|
---|
Net sales
1 |
6.729
|
32.99
|
21.91
|
22.26
|
4.851
|
EBITDA
1 |
-8.894
|
-1.88
|
-3.759
|
-6.368
|
-53.37
|
EBIT
1 |
-12.26
|
-7.422
|
-6.295
|
-8.772
|
-63.64
|
Operating Margin
|
-182.18%
|
-22.5%
|
-28.74%
|
-39.4%
|
-1,311.84%
|
Earnings before Tax (EBT)
1 |
-13.43
|
-10.5
|
-19.34
|
-13.53
|
-71.95
|
Net income
1 |
-13.09
|
-10.26
|
-18.74
|
-12.23
|
-70.98
|
Net margin
|
-194.46%
|
-31.09%
|
-85.55%
|
-54.96%
|
-1,463.13%
|
EPS
2 |
-0.1039
|
-0.0814
|
-0.1487
|
-0.0531
|
-0.2499
|
Free Cash Flow
|
-
|
1.977
|
9.205
|
-
|
-
|
FCF margin
|
-
|
5.99%
|
42.02%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/10/18
|
31/10/19
|
30/10/20
|
28/01/22
|
28/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2023
|
---|
Net Debt
1 |
19.1
|
19.7
|
31.9
|
50.4
|
143
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-2.144
x
|
-10.47
x
|
-8.497
x
|
-7.922
x
|
-2.678
x
|
Free Cash Flow
|
-
|
1.98
|
9.21
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-23%
|
-66.4%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-4.83%
|
-4.18%
|
-
|
-
|
Assets
1 |
-
|
212.3
|
448.2
|
-
|
-
|
Book Value Per Share
2 |
0.3600
|
0.2700
|
0.1700
|
0.3300
|
0.1200
|
Cash Flow per Share
2 |
0.0100
|
0
|
0
|
0.1400
|
0.0200
|
Capex
1 |
3.76
|
0.51
|
0.04
|
125
|
22
|
Capex / Sales
|
55.81%
|
1.55%
|
0.2%
|
560.51%
|
453.44%
|
Announcement Date
|
31/10/18
|
31/10/19
|
30/10/20
|
28/01/22
|
28/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -8.51% | 24.12M | | +8.96% | 27.33B | | +21.48% | 2.38B | | +13.31% | 2.36B | | -50.07% | 2.28B | | -30.74% | 2.07B | | +21.11% | 1.85B | | -15.10% | 1.79B | | +7.13% | 1.33B | | +27.03% | 1.27B |
Medical Supplies
|